Industry ranking
Score of 83.8/100 qualifies for PaymentCheck Certification
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2021 - 30 Jun 2021 | 27 Jul 2021 | 27 | 82% | 14% | 4% | 19% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 26 | 83% | 13% | 4% | 21% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 26 | 83% | 11% | 6% | 24% |
| 01 Jul 2019 - 31 Dec 2019 | 29 Jan 2020 | 26 | 81% | 12% | 7% | 36% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 30 | 73% | 18% | 9% | 41% |
| 01 Apr 2018 - 31 Dec 2018 | 30 Jul 2019 | 29 | 66% | 30% | 4% | 44% |
| 01 Oct 2017 - 31 Mar 2018 | 30 Jul 2019 | 26 | 74% | 22% | 4% | 39% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Payment terms for GW Research Limited cover a variety of different payment terms, subject to the nature of the contract and the invoice. Typical payment terms can include: Immediate 7 Days 14 Days 30 Days 60 Days 20th day of the following month
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
Intercompany invoices and performance have been excluded from reported statistics as these entirely relate to transactions between wholly owned group companies, and would distort performance if included.
Maximum contractual payment period agreed
60
Invoices are matched by a dedicated Accounts Payable team on receipt, and disputed invoices are notified to the supplier. Any disputes are managed directly with the supplier and investigated to resolve them in a timely manner. Disputes may arise due to, but not limited to, the following circumstances: • Non-receipt of invoice • Non-receipt of goods • Delivered product/service does not agree to invoice • Incomplete or incorrect information • Incorrect address or company name • VAT requirements • Change of details (i.e. new bank account)
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
GW Research Limited is a UK-registered company based in Kent, whose registered activity is research and experimental development on biotechnology. Its website now presents the branding of Jazz Pharmaceuticals, indicating it operates as part of the Jazz Pharmaceuticals group. The wider group is described on its site as a global biopharmaceutical company focused on identifying, developing and commercialising medicines for patients with limited or no treatment options, including therapies in areas such as oncology. GW Research Limited's own role sits within this group structure, supporting biotechnology research rather than independently marketing medicines. No separate standalone product or service description for the registered entity itself is provided in the available evidence.
Generated from the company's website and Companies House records. Sources: gwpharm.com